|
| 34962100 | Evaluating the Construct of Damage in Systemic Lupus Erythematosus. | Arthritis Care Res (Hoboken) | 2023 |
| 38030231 | COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series. | RMD Open | 2023 |
| 37085289 | Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. | Ann Rheum Dis | 2023 |
| 37208152 | Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience. | Ann Rheum Dis | 2023 |
| 36642432 | Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases. | J Rheumatol | 2023 |
| 36704930 | Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. | Arthritis Rheumatol | 2023 |
| 37459273 | Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort. | Arthritis Rheumatol | 2023 |
| 36691838 | Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling. | Arthritis Care Res (Hoboken) | 2023 |
| 37044248 | Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study. | Lab Invest | 2023 |
| 37491246 | "I'd like more options!": Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis. | Pediatr Rheumatol Online J | 2023 |
| 35225436 | Measuring the Impact of MyLupusGuide in Canada: Results of a Randomized Controlled Study. | Arthritis Care Res (Hoboken) | 2023 |
| 34962100 | Evaluating the Construct of Damage in Systemic Lupus Erythematosus. | Arthritis Care Res (Hoboken) | 2023 |
| 37491246 | "I'd like more options!": Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis. | Pediatr Rheumatol Online J | 2023 |
| 38030231 | COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series. | RMD Open | 2023 |
| 37459273 | Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort. | Arthritis Rheumatol | 2023 |
| 37085289 | Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. | Ann Rheum Dis | 2023 |
| 37044248 | Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study. | Lab Invest | 2023 |
| 37208152 | Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience. | Ann Rheum Dis | 2023 |
| 36691838 | Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling. | Arthritis Care Res (Hoboken) | 2023 |
| 36642432 | Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases. | J Rheumatol | 2023 |
| 36704930 | Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. | Arthritis Rheumatol | 2023 |
| 35225436 | Measuring the Impact of MyLupusGuide in Canada: Results of a Randomized Controlled Study. | Arthritis Care Res (Hoboken) | 2023 |
| 33152181 | Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index. | Arthritis Care Res (Hoboken) | 2022 |
| 35711439 | Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis. | Front Immunol | 2022 |
| 36175664 | The role of mitochondria in rheumatic diseases. | Nat Rev Rheumatol | 2022 |
| 36283746 | Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic. | Lupus Sci Med | 2022 |
| 35944946 | Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. | Ann Rheum Dis | 2022 |
| 36206383 | Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry"). | Lupus | 2022 |
| 36396267 | Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine. | Lupus Sci Med | 2022 |
| 33152181 | Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index. | Arthritis Care Res (Hoboken) | 2022 |
| 33369255 | Predictors of Unsuccessful Hydroxychloroquine Tapering and Discontinuation: Can We Personalize Decision-Making in Systemic Lupus Erythematosus Treatment? | Arthritis Care Res (Hoboken) | 2022 |
| 33342087 | Challenges of Perceived Self-Management in Lupus. | Arthritis Care Res (Hoboken) | 2022 |
| 35338033 | Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. | Ann Rheum Dis | 2022 |
| 35260475 | Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus. | Lupus Sci Med | 2022 |
| 34911705 | Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. | Ann Rheum Dis | 2022 |
| 35165166 | The Purinergic Receptor P2X4 Promotes Th17 Activation and the Development of Arthritis. | J Immunol | 2022 |
| 35134311 | Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis. | J Cutan Med Surg | 2022 |
| 35128841 | Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2022 |
| 35711439 | Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis. | Front Immunol | 2022 |
| 36396267 | Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine. | Lupus Sci Med | 2022 |
| 36206383 | Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry"). | Lupus | 2022 |
| 36175664 | The role of mitochondria in rheumatic diseases. | Nat Rev Rheumatol | 2022 |
| 36283746 | Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic. | Lupus Sci Med | 2022 |
| 35944946 | Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. | Ann Rheum Dis | 2022 |
| 35128841 | Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2022 |
| 34911705 | Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. | Ann Rheum Dis | 2022 |
| 35338033 | Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. | Ann Rheum Dis | 2022 |
| 35260475 | Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus. | Lupus Sci Med | 2022 |
| 35165166 | The Purinergic Receptor P2X4 Promotes Th17 Activation and the Development of Arthritis. | J Immunol | 2022 |
| 35134311 | Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis. | J Cutan Med Surg | 2022 |